Microbicide Trials Network   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Pittsburgh PA United States (2006)

Organization Overview

First Clinical Trial
2007
NCT00442910
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Microbicides Trial Network

Active Ingredients

Drugs in Phase 2 Trials (3)

dapivirine (1 trial)

emtricitabine (emtriva) (1 trial)

tenofovir (viread) (4 trials)

Drugs in Phase 1 Trials (2)

hydroxyethyl starch (voluven) (2 trials)

spl7013 (VivaGel) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 2)

HIV Infections (Phase 2)

Infections (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 5